Source: ChemRxiv. Unidades: FCF, IGC
Subjects: ANTI-HELMÍNTICOS, CORONAVIRUS, COVID-19
ABNT
BARBOSA, Eduardo José et al. Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses. ChemRxiv, 2020Tradução . . Disponível em: https://doi.org/10.26434/chemrxiv.12056187. Acesso em: 25 set. 2024.APA
Barbosa, E. J., Gubitoso, M. R., Bou-Chacra, N. A., Byrn, S. R., Carvalho, F. M. de S., & Araujo, G. L. B. de. (2020). Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses. ChemRxiv. doi:10.26434/chemrxiv.12056187NLM
Barbosa EJ, Gubitoso MR, Bou-Chacra NA, Byrn SR, Carvalho FM de S, Araujo GLB de. Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses [Internet]. ChemRxiv. 2020 ;[citado 2024 set. 25 ] Available from: https://doi.org/10.26434/chemrxiv.12056187Vancouver
Barbosa EJ, Gubitoso MR, Bou-Chacra NA, Byrn SR, Carvalho FM de S, Araujo GLB de. Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses [Internet]. ChemRxiv. 2020 ;[citado 2024 set. 25 ] Available from: https://doi.org/10.26434/chemrxiv.12056187